#liver cancer

Checkpoint Immunotherapy Looks Promising for Operable Liver Cancer

Bites & Bingo at The Pig and Parrot in Hoboken to benefit the American Liver Foundation.

Immunotherapy led to fewer side effects and better quality of life than standard-of-care therapy.

The International Liver Conference will be held in April 2020.

South Korean researchers found no difference in the rates of liver cancer, liver transplant or death based on the treatment used.

A new study appears to resolve controversy over hep C treatment’s association with mortality risk.

Karen Hoyt promised her grandkids she would win a gold medal in the World Transplant Games. She wasn’t going to let HCC stand in her way.

Researchers compared health outcomes among people with HIV, including those with and without hepatitis C.

Some of the most common and deadly cancers receive little attention and resources.

An analysis conducted in Taiwan analyzed health outcomes over more than a decade.

Researchers analyzed health data regarding modern hep C treatments specific to New South Wales.

Researchers reached this conclusion after reviewing data on more than 30,000 people.

European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.

Phase III study misses statistical threshold, but the immunotherapy appears to show some benefit.

Even positive breaking news looks different to people who know the reality of a hard-to-treat cancer.

Study in China sees an association with several cancer types, especially gastrointestinal malignancies.